Related Experiment Video
Updated: Mar 30, 2026

External Cephalic Version: Is it an Effective and Safe Procedure?
Published on: June 6, 2020
Relationship between etonogestrel level and BMI in women using the contraceptive implant for more than 1 year
Kathleen M Morrell1, Serge Cremers2, Carolyn L Westhoff3
1Department of Obstetrics and Gynecology, Columbia University Medical Center, 622 W 168th Street, PH 16-69, New York, NY, 10032, USA.
Abstract:
Progestin-only contraceptive methods, including the 3-year, single-rod etonogestrel (ENG) implant, may be preferred for obese women to avoid additional estrogen-related thrombosis risk; however, whether obese women receive an ENG sufficient dose to suppress ovulation is understudied. Our analysis expands on the limited information currently available by studying ENG levels related to body mass index (BMI) in a community sample of primarily Hispanic women. This cross-sectional, descriptive study of 52 long-term implant users found comparable ENG levels across a wide BMI range (p=.1). These results further support that ENG levels are independent of BMI through 3 years of implant use and are thus reassuring that ENG implants will be effective for women of all BMIs.
Related Concept Videos
Intrauterine Drug Delivery Systems
Birth Control Methods
Drug Dosing: Obese Patients
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Dosage Regimen: Multiple Oral Dosage
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

